Meribank Biotech Co., Ltd (TPEX:4724)

Meribank Biotech Statistics

Total Valuation

TPEX:4724 has a market cap or net worth of TWD 1.29 billion. The enterprise value is 2.19 billion.

Market Cap	1.29B
Enterprise Value	2.19B

Important Dates

The next estimated earnings date is Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4724 has 87.98 million shares outstanding. The number of shares has increased by 15.01% in one year.

Current Share Class	87.98M
Shares Outstanding	87.98M
Shares Change (YoY)	+15.01%
Shares Change (QoQ)	-0.11%
Owned by Insiders (%)	41.01%
Owned by Institutions (%)	n/a
Float	39.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.73
PB Ratio	1.02
P/TBV Ratio	3.06
P/FCF Ratio	15.05
P/OCF Ratio	14.41
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.13, with an EV/FCF ratio of 25.59.

EV / Earnings	-26.89
EV / Sales	4.64
EV / EBITDA	22.13
EV / EBIT	n/a
EV / FCF	25.59

Financial Position

The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.89.

Current Ratio	1.90
Quick Ratio	1.71
Debt / Equity	0.89
Debt / EBITDA	10.91
Debt / FCF	13.08
Interest Coverage	-2.28

Financial Efficiency

Return on equity (ROE) is -6.63% and return on invested capital (ROIC) is -1.45%.

Return on Equity (ROE)	-6.63%
Return on Assets (ROA)	-1.19%
Return on Invested Capital (ROIC)	-1.45%
Return on Capital Employed (ROCE)	-2.01%
Weighted Average Cost of Capital (WACC)	4.47%
Revenue Per Employee	3.32M
Profits Per Employee	-573,697
Employee Count	142
Asset Turnover	0.17
Inventory Turnover	30.52

Taxes

Income Tax	-6.78M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.42% in the last 52 weeks. The beta is 0.49, so TPEX:4724's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	-13.42%
50-Day Moving Average	14.46
200-Day Moving Average	16.76
Relative Strength Index (RSI)	38.14
Average Volume (20 Days)	92,902

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4724 had revenue of TWD 471.76 million and -81.47 million in losses. Loss per share was -0.89.

Revenue	471.76M
Gross Profit	202.18M
Operating Income	-52.78M
Pretax Income	-88.94M
Net Income	-81.47M
EBITDA	102.63M
EBIT	-52.78M
Loss Per Share	-0.89

Balance Sheet

The company has 229.34 million in cash and 1.12 billion in debt, with a net cash position of -890.86 million or -10.13 per share.

Cash & Cash Equivalents	229.34M
Total Debt	1.12B
Net Cash	-890.86M
Net Cash Per Share	-10.13
Equity (Book Value)	1.26B
Book Value Per Share	13.14
Working Capital	223.08M

Cash Flow

In the last 12 months, operating cash flow was 89.45 million and capital expenditures -3.84 million, giving a free cash flow of 85.62 million.

Operating Cash Flow	89.45M
Capital Expenditures	-3.84M
Depreciation & Amortization	155.41M
Net Borrowing	-77.95M
Free Cash Flow	85.62M
FCF Per Share	0.97

Margins

Gross margin is 42.86%, with operating and profit margins of -11.19% and -17.27%.

Gross Margin	42.86%
Operating Margin	-11.19%
Pretax Margin	-18.85%
Profit Margin	-17.27%
EBITDA Margin	21.76%
EBIT Margin	-11.19%
FCF Margin	18.15%

Dividends & Yields

TPEX:4724 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.01%
Shareholder Yield	-15.01%
Earnings Yield	-6.32%
FCF Yield	6.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4